Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scienture Holdings (SCNX) Cash & Equivalents (2016 - 2025)

Scienture Holdings (SCNX) has disclosed Cash & Equivalents for 13 consecutive years, with $6.7 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 2062.32% to $6.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.7 million through Dec 2025, up 2062.32% year-over-year, with the annual reading at $6.7 million for FY2025, 2062.32% up from the prior year.
  • Cash & Equivalents hit $6.7 million in Q4 2025 for Scienture Holdings, up from $15391.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $7.7 million in Q2 2024 to a low of $15391.0 in Q2 2025.
  • Historically, Cash & Equivalents has averaged $2.5 million across 5 years, with a median of $1.9 million in 2022.
  • Biggest YoY gain for Cash & Equivalents was 2062.32% in 2025; the steepest drop was 99.8% in 2025.
  • Year by year, Cash & Equivalents stood at $3.1 million in 2021, then plummeted by 64.94% to $1.1 million in 2022, then tumbled by 86.13% to $151907.0 in 2023, then soared by 102.82% to $308096.0 in 2024, then skyrocketed by 2062.32% to $6.7 million in 2025.
  • Business Quant data shows Cash & Equivalents for SCNX at $6.7 million in Q4 2025, $15391.0 in Q2 2025, and $2.0 million in Q1 2025.